SCYNEXIS (SCYX) Competitor Comparison
We are evaluating the key criteria listed to compare SCYNEXIS (SCYX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
44 / 54Gross Profits
0 / 39Total Revenue
31 / 50EBITDA
20 / 53Free Cashflow
21 / 54Quick Ratio
6 / 54Earnings per Share
33 / 54Dividend yield
0 / 5Total Cash
28 / 54Performance 3 years
38 / 54Performance 5 years
44 / 54Performance 10 years
51 / 54Linearity 3 years
40 / 54Linearity 5 years
43 / 54Linearity 10 years
49 / 54Total Rank
51 / 54Dividend Rank
33 / 54Valuation Rank
52 / 54Piotroski Rank
52 / 54Muliplier Rank
52 / 54Market Capitalization - SCYX ranking 44 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.